Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Lersivirine

Generic Name: Lersivirine

Drug Type: Small Molecule

Chemical Formula: C_₁₇H_₁₈N_₄O_₂

CAS Number: 473921-12-9

Unique Ingredient Identifier: R3ZGC15A9A

Overview

Lersivirine has been used in trials studying the treatment of HIV-1.

Background

Lersivirine has been used in trials studying the treatment of HIV-1.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects

Phase 1

Completed

Posted: 2012/05/22

Sponsor:Pfizer

ID:NCT01603485

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

Phase 2

Terminated

Posted: 2010/12/06

Sponsor:Pfizer

ID:NCT01254656

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

Phase 1

Completed

Posted: 2010/10/29

Sponsor:Pfizer

ID:NCT01230385

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

Phase 1

Completed

Posted: 2010/10/13

Sponsor:Pfizer

ID:NCT01220232

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of S- And R-Methadone

Phase 1

Completed

Posted: 2010/04/07

Sponsor:Pfizer

ID:NCT01099748

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy